Monolaurin

Drug Profile

Monolaurin

Alternative Names: Glycerol monolaurate; Glylorin; T 100

Latest Information Update: 07 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cellegy Pharmaceuticals
  • Class Anti-inflammatories; Antipruritics; Glycerides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Atopic dermatitis; Congenital ichthyosiform erythroderma; Ichthyosis; Impetigo

Most Recent Events

  • 31 Dec 2006 Discontinued - Phase-II for Ichthyosis in USA (Topical)
  • 31 Dec 2006 Discontinued - Phase-III for Congenital ichthyosiform erythoderma in USA (unspecified route)
  • 13 Mar 2001 Discontinued-I for Impetigo in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top